Skip to main content
OpenTrials

Clinical trial condition

Dermatomyositis

Explore clinical trials studying Dermatomyositis. Study availability and eligibility vary by location and protocol.

138 public trials 45 recruiting studies
Refine in advanced search Browse all conditions

Dermatomyositis trial results

Not Yet Recruiting

Phase 2 Trial to Evaluate the Efficacy, Safety of Allogeneic Mitochondria (PN-101) in Patients With Refractory Polymyositis or Dermatomyositis

NCT07122648

Conditions
Connective Tissue Diseases, Dermatomyositis, Muscular Diseases, +7 more
Locations
  • Chung-Ang University Gwang Myeong Hospital Gwangmyeong, Gyeonggi-do, South Korea
  • Kyung Hee University Medical Center Seoul, South Korea
  • Seoul National University Seoul, South Korea
  • Soon Chun Hyang University Hospital Seoul Seoul, South Korea
View Trial Details
Completed

Environmental Risk Factors for Myositis in Military Personnel

NCT01734369

Conditions
Adult Polymyositis, Connective Tissue Diseases, Dermatomyositis, +10 more
Locations
  • Miami VA Healthcare System Miami, Florida, United States
  • Walter Reed National Medical Center Bethesda, Maryland, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • NIEHS Clinical Research Unit (CRU) Research Triangle Park, North Carolina, United States
View Trial Details
Completed

A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.

NCT05523167

Conditions
Active Idiopathic Inflammatory Myopathy, Antisynthetase Syndrome, Antisynthetase syndrome, +11 more
Locations
  • Neuromuscular Research Center Phoenix, Arizona, United States
  • HonorHealth Neurology - Bob Bove Neuroscience Institute - Neurology Scottsdale, Arizona, United States
  • Attune Health Research, Inc Beverly Hills, California, United States
  • University of Southern California Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 202 locations
View Trial Details
Completed

A Study Evaluating the Effects of GLPG3667 Given as Oral Treatment for up to 24 Weeks in Adults With Dermatomyositis

NCT05695950

Conditions
Connective Tissue Diseases, Dermatomyositis, Muscular Diseases, +7 more
Locations
  • HonorHealth Neurology Scottsdale, Arizona, United States
  • Inland Rheumatology Clinical Trials, Inc. Upland, California, United States
  • New Access Research and Medical Center Kendall, Florida, United States
  • Omega Research Orlando, LLC Orlando, Florida, United States
View all 54 locations
View Trial Details

Related conditions